iBio (IBIO) Consolidated Net Income (2016 - 2025)
Historic Consolidated Net Income for iBio (IBIO) over the last 17 years, with Q4 2025 value amounting to -$9.0 million.
- iBio's Consolidated Net Income fell 10607.24% to -$9.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$24.7 million, marking a year-over-year decrease of 8430.19%. This contributed to the annual value of -$18.4 million for FY2025, which is 9417.79% down from last year.
- According to the latest figures from Q4 2025, iBio's Consolidated Net Income is -$9.0 million, which was down 10607.24% from -$5.7 million recorded in Q3 2025.
- iBio's 5-year Consolidated Net Income high stood at -$537000.0 for Q1 2024, and its period low was -$23.0 million during Q4 2022.
- Moreover, its 5-year median value for Consolidated Net Income was -$4.8 million (2021), whereas its average is -$5.8 million.
- In the last 5 years, iBio's Consolidated Net Income soared by 9365.62% in 2023 and then crashed by 80521.42% in 2025.
- Over the past 5 years, iBio's Consolidated Net Income (Quarter) stood at -$4.7 million in 2021, then crashed by 386.15% to -$23.0 million in 2022, then soared by 83.81% to -$3.7 million in 2023, then fell by 17.22% to -$4.4 million in 2024, then crashed by 106.07% to -$9.0 million in 2025.
- Its last three reported values are -$9.0 million in Q4 2025, -$5.7 million for Q3 2025, and -$5.2 million during Q2 2025.